SYS-CON MEDIA Authors: Lori MacVittie, RealWire News Distribution, Cynthia Dunlop, Mark O'Neill, Kevin Benedict

News Feed Item

Tyber Medical Announces Strategic Partnership to Provide Customer Financing

MORRISTOWN, N.J., Feb. 18, 2014 /PRNewswire/ -- Tyber Medical, LLC, a privately held medical device company focused on developing innovative spine and orthopedic devices for private label opportunities, announced today that they have formed a partnership with Magellan Capital Partners of Tustin, CA. This strategic alliance will allow Magellan Capital Partners to provide financing services to Tyber Medical's private label partners to facilitate market entry with new products.

(Logo: http://photos.prnewswire.com/prnh/20140218/NY66889LOGO )

Tyber Medical, LLC, a market leader in titanium plasma spray coated spinal implants, has partnered with Magellan Capital Partners to further support their mission to provide rapid access to the latest technology in regulatory cleared implants. Steve Zeiger, Tyber Medical's Director of Sales and Marketing, commented, "Entering the OR suite requires a level of preparedness that can sometimes deter private label partners from capitalizing on the opportunity to bring Tyber Medical's innovative products to market under their own brand due to the required investment. Magellan Capital Partners offer financing options to spread the investment over time and allow a quick path to profitability."

"Magellan Capital Partners is excited about this new partnership. We pride ourselves on being a full service equipment finance company and value our strategic partnerships. We're fortunate to be able to partner with Tyber Medical, LLC, to bring this value added service to their partners," said Tony Sherwin.

About Tyber Medical:

Tyber Medical, LLC, Morristown, New Jersey, is focused on addressing an industry-wide need for rapid access to regulatory approved orthopedic implants. These implants are most often used in conjunction with proprietary branded devices produced by companies ranging from start-ups to large corporations.  Tyber Medical is working on several innovative medical devices with the potential to improve patient outcomes at a lower overall cost to healthcare systems.  They are certified ISO 13485 and currently produce and market FDA approved and CE marked spinal interbody spacers and instruments featuring both a standard sterile and non-sterile PEEK and TyPEEK™, a proprietary titanium plasma sprayed PEEK. The spacers include configurations for Anterior Cervical (ACIF), Anterior Lumbar (ALIF), Posterior Lumbar (PLIF), Oblique Lumbar (OLIF), Transforaminal Lumbar (TLIF), and Direct Lateral (DLIF) Interbody Spacers. For more information visit www.tybermedical.com.

About Magellan Capital Partners:

Magellan Capital Partners, Tustin, California, is an independent, full-service national equipment leasing and financing institution whose primary focus is to provide creative and flexible financing options for commercial entities and equipment suppliers.  They offer competitive rates and excellent service to clients and equipment suppliers in order to form long-term partnerships built on trust, flexibility and positive outcomes.  Magellan Capital Partners' financing programs are customized and structured to meet the needs of both customers and equipment suppliers.  They take responsibility for the entire transaction, from the receipt of the application, to financial analysis and documentation, to final funding.  Anthony Sherwin, Founder and President of the company, has over 25 years of experience in the equipment leasing and financing industry.  For more information visit www.magellancappartners.com.

Contact:

Steve Zeiger
89 Headquarters Plaza North, #1464
Morristown, New Jersey 07960
(866) 761-0933
szeiger@tybermed.com

SOURCE Tyber Medical

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.